Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 153 participants.

Also called NCT07049120

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 153 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07049120
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07049120. Allocation not applicable; no masking; primary purpose prevention. Start 2025-06-30 (anticipated); primary completion 2027-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions
Condition
Peripheral Arterial Disease
Intervention (Device)
ZENFLEX Pro™ Peripheral Drug-eluting Stent System
Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07049120
Content hash
72fc352941c32817367c1ab670ce1cef72f7b489fe3cdcc7180fcbb7c16eba7a